AIMProteus
             AKT Inhibitor Miransertib on Proteus Syndrome  - Targeted therapy at NIH

Update:  The AIM Proteus Trial is currently is currently on hold.

Approximate patient enrollment date for trial - Late Feb-March 2020

The NIH team is very excited about the opening of this phase 2 clinical trial. They will be hosting an Educational Information Session Webinar on Tuesday, January 21st at 11:00am eastern standard time. concerning:

• trial status 
• the next steps for enrollment 

Questions about the NIH AIMProteus trial email here or call.